Abstract
Amyotrophic lateral sclerosis (ALS) is an adult-onset degenerative disorder characterised by the death of motor neurons in the cortex, brainstem, and spinal cord; resulting in progressive muscle weakness, atrophy, and death from respiratory paralysis, usually within 3-5 years of symptom onset. Approximately 10% of ALS cases are familial (FALS). Mutations in superoxide dismutase-1 (SOD1) cause approximately 20% of FALS cases and there is overwhelming evidence that a toxic gain of function is the cause of the disease. We have previously shown that FALS-associated SOD1 disease mutants enhanced neuronal death in response to a wide range of stimuli tested whereas wt-SOD1 protected against all insults. We demonstrate for the first time that over-expression of either heat shock protein Hsp27 or Hsp70 has a protective effect against SOD1 disease associated mutant-induced cell death. However, over-expression of Hsp27 and Hsp70 together has a greater potent anti-apoptotic effect, than when expressed singly, against the damaging effects of mutant SOD1. Our results indicate that FALS-associated SOD1 disease mutants possess enhanced death-inducing properties and lead to increased apoptosis which can be prevented by either the use of specific caspase inhibitors or Hsp27 and/or Hsp70 over-expression. This potent protective effect of Hsp27 and Hsp70 against the FALS-associated SOD1 disease mutants may be of potential therapeutic importance.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Chloromethyl Ketones / pharmacology
-
Amyotrophic Lateral Sclerosis / genetics
-
Amyotrophic Lateral Sclerosis / pathology
-
Amyotrophic Lateral Sclerosis / physiopathology
-
Amyotrophic Lateral Sclerosis / prevention & control*
-
Analysis of Variance
-
Animals
-
Animals, Newborn
-
Blotting, Western / methods
-
Cell Death / drug effects
-
Cell Death / genetics
-
Cells, Cultured
-
Cricetinae
-
Culture Media, Serum-Free / pharmacology
-
Disease Models, Animal
-
Drug Combinations
-
Drug Interactions
-
Enzyme Inhibitors / pharmacology
-
Ganglia, Spinal / cytology*
-
Genetic Vectors / physiology
-
Green Fluorescent Proteins / metabolism
-
HIV-1 / physiology
-
HSP27 Heat-Shock Proteins
-
HSP70 Heat-Shock Proteins / administration & dosage*
-
Heat-Shock Proteins / administration & dosage*
-
In Situ Nick-End Labeling / methods
-
Mutagenesis / physiology
-
Mutation
-
Neoplasm Proteins / administration & dosage*
-
Neurons / drug effects*
-
Neuroprotective Agents / pharmacology
-
Rats
-
Staurosporine / pharmacology
-
Superoxide Dismutase / genetics
-
Superoxide Dismutase-1
-
Time Factors
-
Transfection / methods
Substances
-
Amino Acid Chloromethyl Ketones
-
Culture Media, Serum-Free
-
Drug Combinations
-
Enzyme Inhibitors
-
HSP27 Heat-Shock Proteins
-
HSP70 Heat-Shock Proteins
-
Heat-Shock Proteins
-
Hspb1 protein, rat
-
Neoplasm Proteins
-
Neuroprotective Agents
-
benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
-
Green Fluorescent Proteins
-
Sod1 protein, rat
-
Superoxide Dismutase
-
Superoxide Dismutase-1
-
Staurosporine